The global infection control market was valued at USD 214.0 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. This steady growth is largely driven by the increasing number of surgical and clinical procedures that require rigorous infection prevention measures. The demand for infection control solutions is also closely linked to the improved clinical outcomes seen when infection control practices are properly implemented. These outcomes not only help improve patient safety but also ensure the efficacy of medical treatments and procedures.

A significant factor fueling the market’s growth is the ongoing demand for sterilization and disinfection across a range of sectors, particularly within hospitals, clinics, pharmaceutical companies, and medical device manufacturers. The COVID-19 pandemic has further amplified this demand, as hospitals and healthcare facilities globally had to implement strict infection control measures to prevent the spread of the virus. As a result, there was a surge in the need for disinfection technologies, sterilization equipment, and other infection control products, thus positively influencing the market.

A major health concern that underpins the demand for infection control solutions is the high incidence of acute respiratory diseases (ARDs), which are responsible for a significant number of global deaths. According to data from the World Health Organization (WHO), ARDs are among the leading causes of mortality worldwide, accounting for approximately 4.0 million deaths annually. This highlights the critical need for effective infection prevention and control measures in healthcare settings to combat the spread of respiratory infections, as well as other hospital-acquired infections (HAIs).

Gather more insights about the market drivers, restrains and growth of the Infection Control market

Regional Insights

North America

North America led the infection control market in 2022, capturing the largest revenue share of over 30%. This dominant share is primarily attributed to a combination of strategic collaborations, innovation, and expansion efforts by key companies operating in the region. Many of the leading players in the market are focusing on strengthening their infection control product portfolios and increasing their presence across North America, which further solidifies its market leadership.

For example, Advanced Sterilization Products (ASP), a prominent player in the infection control space, made significant strides by launching the STERRAD 100NX System with ALLClear in January 2017 in the U.S.. This system offers enhanced sterilization capabilities, and ASP also planned to expand its presence into other regions, including Europe, Africa, and the Middle East. Moreover, in 2020, ASP received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its STERRAD VELOCITY® Biological Indicator, a device used within the STERRAD System that offers the fastest instrument sterilization results in healthcare settings, completing sterilization in 15 minutes. This focus on continuous product innovation and regulatory approvals has further contributed to North America's leading position in the infection control market.

Asia Pacific

Asia Pacific is expected to witness the fastest compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. The region’s rapid expansion is driven by several factors, including the growing number of outsourcing organizations, rising healthcare expenditure, and the ongoing improvement in healthcare infrastructure and standards. Governments across the region are increasingly focusing on enhancing infection control measures, a key driver of market growth.

Additionally, the growing trend of outsourcing infection control services from developed markets to the Asia Pacific region is significantly influencing the market's development. This trend is being driven by cost-effective solutions, access to skilled labor, and the growing adoption of advanced infection control practices in the region. For example, the Asia Pacific Society of Infection Control (APSIC), a voluntary organization, works toward improving infection control standards and promoting collaborative partnerships for cost-efficient practices. APSIC also conducts research and advocates for the implementation of evidence-based infection control solutions, which directly support the market’s growth in this region.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global medical washer disinfector market size was estimated at USD 2,005.88 million in 2024 and is projected to grow at a CAGR of 6.11% from 2025 to 2030. 

• The global laboratory equipment market size was estimated at USD 28.03 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.62% from 2023 to 2030.

Key Companies & Market Share Insights

The infection control market is highly competitive, characterized by strategic initiatives and collaborations between leading companies. Some of the dominant players in the market include Advanced Sterilization Products, STERIS Corporation, and Cantel Medical Corporation, among others. These companies have established a solid presence through various growth strategies, such as mergers and acquisitions, new product development, and geographical expansion.

For instance, Midmark Corp., a company specializing in dental solutions, launched the Sterilizer Data Logger and M3 Steam Sterilizer in September 2020. This new product line is designed to provide speed, compliance, and simplicity in processing medical instruments, further enhancing infection control processes in healthcare facilities.

In November 2020, Applicon Biotechnology, a part of the Getinge Group, introduced the AppliFlex ST, a customizable single-use bioreactor. This product is designed to optimize lab processes and reduce labor hours, making it a valuable tool in biotech and pharmaceutical industries focused on infection prevention.

Key Infection Control Companies:

• 3M

• Belimed AG

• O&M Halyard or its affiliates.

• Getinge Group

• ASP

• MATACHANA

• Sterigenics U.S., LLC – A Sotera Health company

• MMM Group

• Cantel Medical Corp.

• STERIS plc.

• Midmark Corporation.

• Medivators Inc

• W&H

Order a free sample PDF of the Infection Control Market Intelligence Study, published by Grand View Research.